Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma - PubMed (original) (raw)
Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma
Jordi Rimola et al. Hepatology. 2009 Sep.
Abstract
This study assesses the magnetic resonance (MR) features of intrahepatic cholangiocarcinoma (ICC) in patients with cirrhosis with specific analysis of the contrast enhancement pattern. Cholangiocarcinoma may show increased contrast uptake in the arterial phase, and, if washout in the delayed venous phase were to be detected, the noninvasive diagnostic criteria proposed in the American Association for the Study of Liver Diseases guidelines would be refuted. We reviewed the MR findings of 25 patients with cirrhosis with 31 histologically confirmed ICC nodules. Signal intensity on basal T1-weighted and T2-weighted images and characteristics of enhancement after contrast administration on arterial, portal, and delayed phase were registered. Enhancement pattern was defined according to the behavior of the lesions in each phase, and dynamic pattern was described according to the progression of enhancement throughout the different phases. The most frequent pattern displayed by ICC was a progressive contrast uptake (80.6%). Stable contrast enhancement was registered in 19.4%. None of the ICCs showed a washout pattern, a profile that is specific for hepatocellular carcinoma (HCC). The ICC dynamic behavior differed significantly according to tumor size: progressive enhancement pattern was the most frequent (20 of 25 cases) in lesions larger than 20 mm, whereas the stable pattern was mainly identified in nodules smaller than 20 mm. The most characteristic MR contrast pattern in ICC in cirrhosis is a progressive contrast uptake throughout the different phases, whereas contrast washout at delayed phases is not observed. Because stable enhancement pattern without washout also can be registered in small HCC nodules, the evaluation of delayed phase is mandatory for a proper nodule characterization. If washout is not registered, a biopsy should be mandatory for diagnosis.
Comment in
- Comments on minimizing misdiagnosis of hepatocellular carcinoma from magnetic resonance imaging.
Cho YK. Cho YK. Hepatology. 2009 Oct;50(4):1316; author reply 1316-7. doi: 10.1002/hep.23177. Hepatology. 2009. PMID: 19790088 No abstract available.
Similar articles
- Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
Yu JS, Lee JH, Chung JJ, Kim JH, Kim KW. Yu JS, et al. Acta Radiol. 2008 Sep;49(7):735-43. doi: 10.1080/02841850802120045. Acta Radiol. 2008. PMID: 18608015 - Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma.
Leyendecker JR, Gakhal M, Elsayes KM, McDermott R, Narra VR, Brown JJ. Leyendecker JR, et al. J Comput Assist Tomogr. 2008 Mar-Apr;32(2):178-84. doi: 10.1097/RCT.0b013e31806bef8e. J Comput Assist Tomogr. 2008. PMID: 18379298 - Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
Chung JJ, Kim MJ, Kim KW. Chung JJ, et al. J Magn Reson Imaging. 2006 May;23(5):706-11. doi: 10.1002/jmri.20557. J Magn Reson Imaging. 2006. PMID: 16565954 Clinical Trial. - MR imaging of hepatocellular carcinoma.
Onaya H, Itai Y. Onaya H, et al. Magn Reson Imaging Clin N Am. 2000 Nov;8(4):757-68. Magn Reson Imaging Clin N Am. 2000. PMID: 11149678 Review. - Magnetic resonance imaging of cholangiocarcinoma.
Manfredi R, Barbaro B, Masselli G, Vecchioli A, Marano P. Manfredi R, et al. Semin Liver Dis. 2004 May;24(2):155-64. doi: 10.1055/s-2004-828892. Semin Liver Dis. 2004. PMID: 15192788 Review.
Cited by
- Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging.
Rimola J, Planell N, Rodríguez S, Delgado S, Ordás I, Ramírez-Morros A, Ayuso C, Aceituno M, Ricart E, Jauregui-Amezaga A, Panés J, Cuatrecasas M. Rimola J, et al. Am J Gastroenterol. 2015 Mar;110(3):432-40. doi: 10.1038/ajg.2014.424. Epub 2015 Jan 27. Am J Gastroenterol. 2015. PMID: 25623654 - The challenges of novel contrast agents for the imaging diagnosis of hepatocellular carcinoma.
Ayuso C, Bruix J. Ayuso C, et al. Hepatol Int. 2014 Jan;8(1):4-6. doi: 10.1007/s12072-013-9505-5. Epub 2013 Dec 28. Hepatol Int. 2014. PMID: 26202400 No abstract available. - Imaging Diagnosis of Various Hepatocellular Carcinoma Subtypes and Its Hypervascular Mimics: Differential Diagnosis Based on Conventional Interpretation and Artificial Intelligence.
Minami Y, Nishida N, Kudo M. Minami Y, et al. Liver Cancer. 2022 Dec 6;12(2):103-115. doi: 10.1159/000528538. eCollection 2023 Jun. Liver Cancer. 2022. PMID: 37325493 Free PMC article. Review. - Intrahepatic Cholangiocarcinoma.
Entezari P, Riaz A. Entezari P, et al. Semin Intervent Radiol. 2020 Dec;37(5):475-483. doi: 10.1055/s-0040-1719188. Epub 2020 Dec 11. Semin Intervent Radiol. 2020. PMID: 33328703 Free PMC article. Review. - Cholangiocarcinoma: another masquerader in the making?
Gnanapandithan K, Allaparthi S, Ukena T, Anand C. Gnanapandithan K, et al. J Gastrointest Cancer. 2014 Dec;45 Suppl 1:14-7. doi: 10.1007/s12029-013-9518-2. J Gastrointest Cancer. 2014. PMID: 23824629 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical